YMAB Insider Trading (Y-mAbs Therapeutics)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 38.40%

Insider Buying (Last 12 Months): $78,853.35

Insider Selling (Last 12 Months): $18,751,936.75

Y-mAbs Therapeutics Insider Trading History Chart

Y-mAbs Therapeutics Share Price & Price History

^$26.38

▼ -2.11 (-7.41%)

As of 04/9/2021 01:00 AM ET

Days: 30 | 90 | 365

Gain the Knowledge You Need to Successfully Trade Futures Markets

From RJO Futures | Ad

Our Technical Analysis Guide will give you the insight into today’s fast-moving markets. It’s designed to give you a head start in learning the basics of various TA tools and techniques.

Download Your Complimentary Technical Analysis Guide TODAY!

Y-mAbs Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/15/2021	Thomas Gad	Insider	Sell	7,000	$36.79	$257,530.00	7,000
1/19/2021	David N Gill	Director	Sell	2,000	$46.52	$93,040.00	2,000
1/19/2021	Thomas Gad	Insider	Sell	7,000	$46.51	$325,570.00	7,000
1/5/2021	Thomas Gad	Insider	Sell	7,000	$49.36	$345,520.00	7,000
12/28/2020	Thomas Gad	Insider	Sell	7,000	$51.98	$363,860.00	7,000
12/16/2020	Thomas Gad	Insider	Sell	7,000	$53.01	$371,070.00	7,000
12/14/2020	Thomas Gad	Insider	Sell	4,000	$52.89	$211,560.00
12/10/2020	Thomas Gad	Insider	Sell	50,000	$50.75	$2,537,500.00	50,000
12/2/2020	Pedro Claus Juan Moller-San	CEO	Sell	40,734	$51.27	$2,088,432.18	15,625
12/2/2020	Vignesh Rajah	CMO	Buy	233	$51.03	$11,889.99
12/1/2020	Thomas Gad	Chairman	Sell	4,000	$51.42	$205,680.00
11/17/2020	Vignesh Rajah	CMO	Buy	1,464	$45.74	$66,963.36
11/3/2020	David N Gill	Director	Sell	4,000	$45.00	$180,000.00	4,000
10/15/2020	Thomas Gad	Chairman	Sell	4,000	$39.15	$156,600.00
10/1/2020	Thomas Gad	Chairman	Sell	4,000	$38.88	$155,520.00
9/14/2020	Thomas Gad	Chairman	Sell	22,569	$41.00	$925,329.00	13,860
9/11/2020	Thomas Gad	Chairman	Sell	13,571	$40.33	$547,318.43	13,860
9/1/2020	Thomas Gad	Chairman	Sell	4,000	$41.60	$166,400.00
8/17/2020	Thomas Gad	Chairman	Sell	4,000	$40.35	$161,400.00
8/11/2020	Thomas Gad	Chairman	Sell	37,000	$40.06	$1,482,220.00
7/15/2020	Thomas Gad	Chairman	Sell	4,000	$40.06	$160,240.00
6/15/2020	Thomas Gad	Chairman	Sell	4,000	$43.45	$173,800.00
6/4/2020	Thomas Gad	Chairman	Sell	4,000	$41.61	$166,440.00
5/26/2020	Mahiuddin Ahmed	VP	Sell	50,000	$39.38	$1,969,000.00	150,000
5/13/2020	Bo Kruse	CFO	Sell	14,724	$37.86	$557,450.64	285,276
5/13/2020	Pedro Claus Juan Moller-San	CEO	Sell	60,846	$37.75	$2,296,936.50	15,625
5/12/2020	Mahiuddin Ahmed	VP	Sell	20,000	$39.19	$783,800.00	240,000
5/12/2020	Thomas Gad	Chairman	Sell	50,000	$39.04	$1,952,000.00
4/13/2020	Thomas Gad	Chairman	Sell	4,000	$29.43	$117,720.00
3/17/2020	Pedro Claus Juan Moller-San	CEO	Buy	1,900	$17.22	$32,718.00	15,625
3/16/2020	Thomas Gad	Chairman	Sell	4,000	$18.01	$72,040.00
2/10/2020	Thomas Gad	Chairman	Sell	4,000	$33.03	$132,120.00
1/27/2020	Thomas Gad	Chairman	Sell	4,000	$35.06	$140,240.00
1/13/2020	Thomas Gad	Chairman	Sell	4,000	$30.90	$123,600.00
12/16/2019	Thomas Gad	Chairman	Sell	4,000	$31.54	$126,160.00
12/2/2019	Thomas Gad	Chairman	Sell	4,000	$32.48	$129,920.00
11/18/2019	Thomas Gad	Chairman	Sell	4,000	$28.85	$115,400.00
11/4/2019	Thomas Gad	Chairman	Sell	4,000	$30.01	$120,040.00
10/30/2019	James Healy	Director	Buy	90,000	$29.79	$2,681,100.00
10/21/2019	Thomas Gad	Chairman	Sell	4,000	$31.65	$126,600.00
10/18/2019	Thomas Gad	CEO	Sell	7,250	$16.71	$121,147.50
10/7/2019	Thomas Gad	Chairman	Sell	4,000	$25.21	$100,840.00
9/16/2019	Thomas Gad	Chairman	Sell	4,000	$30.59	$122,360.00
9/6/2019	Johan Wedell-Wedellsborg	Director	Sell	17,243	$27.00	$465,561.00
9/3/2019	Thomas Gad	Chairman	Sell	4,000	$25.77	$103,080.00
8/30/2019	Johan Wedell-Wedellsborg	Director	Sell	89,166	$26.58	$2,370,032.28
8/28/2019	Johan Wedell-Wedellsborg	Director	Sell	49,357	$27.08	$1,336,587.56
8/21/2019	Johan Wedell-Wedellsborg	Director	Sell	168,244	$27.57	$4,638,487.08
8/19/2019	Thomas Gad	Insider	Sell	4,000	$27.70	$110,800.00
8/5/2019	Thomas Gad	Insider	Sell	4,000	$21.78	$87,120.00
7/22/2019	Thomas Gad	Insider	Sell	4,000	$22.54	$90,160.00
7/8/2019	Thomas Gad	Insider	Sell	4,000	$22.40	$89,600.00
6/24/2019	Thomas Gad	Insider	Sell	4,000	$21.77	$87,080.00
6/10/2019	Thomas Gad	Insider	Sell	4,000	$22.79	$91,160.00
6/3/2019	Thomas Gad	Insider	Sell	4,000	$20.03	$80,120.00
5/28/2019	Thomas Gad	Insider	Sell	6,000	$20.21	$121,260.00
5/13/2019	Thomas Gad	Insider	Sell	6,000	$20.61	$123,660.00
4/11/2019	Thomas Gad	Insider	Sell	250,000	$25.89	$6,472,500.00
9/25/2018	Ashu Tyagi	Director	Buy	430,174	$16.00	$6,882,784.00
9/25/2018	Moller San Pedro Claus Juan	CEO	Buy	31,250	$16.00	$500,000.00
9/21/2018	James Healy	Director	Buy	500,000	$16.00	$8,000,000.00

SEC Filings (Institutional Ownership Changes) for Y-mAbs Therapeutics (NASDAQ:YMAB)

53.20% of Y-mAbs Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Y-mAbs Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/5/2021	Pacer Advisors Inc.	1,812	$55K	0.0%	+137.2%	0.004%
3/26/2021	Susquehanna International Group LLP	6,815	$0.34M	0.0%	+28.2%	0.016%
3/12/2021	DekaBank Deutsche Girozentrale	12,700	$0.64M	0.0%	-4.5%	0.029%
2/23/2021	Principal Financial Group Inc.	16,008	$0.79M	0.0%	+92.8%	0.040%
2/19/2021	JPMorgan Chase & Co.	30,007	$1.49M	0.0%	+1.1%	0.074%
2/17/2021	Jane Street Group LLC	20,607	$1.02M	0.0%	+132.5%	0.051%
2/16/2021	Squarepoint Ops LLC	19,715	$0.98M	0.0%	+26.9%	0.049%
2/16/2021	Morgan Stanley	132,285	$6.55M	0.0%	+75.5%	0.327%
2/16/2021	Brookfield Asset Management Inc.	44,000	$2.18M	0.0%	N/A	0.109%
2/16/2021	Rice Hall James & Associates LLC	100,994	$5M	0.2%	+6.8%	0.249%
2/16/2021	Nuveen Asset Management LLC	138,994	$6.88M	0.0%	+16.5%	0.343%
2/16/2021	Ashford Capital Management Inc.	219,419	$10.86M	1.1%	N/A	0.542%
2/16/2021	Charles Schwab Investment Management Inc.	177,476	$8.79M	0.0%	+3.0%	0.438%
2/12/2021	Penserra Capital Management LLC	930	$46K	0.0%	+171.9%	0.002%
2/12/2021	Federated Hermes Inc.	22,152	$1.10M	0.0%	-79.7%	0.055%
2/12/2021	Amalgamated Bank	4,764	$0.24M	0.0%	N/A	0.012%
2/12/2021	The Manufacturers Life Insurance Company	18,573	$0.92M	0.0%	+4.1%	0.046%
2/12/2021	Credit Suisse AG	27,939	$1.38M	0.0%	-5.2%	0.069%
2/12/2021	Virtus ETF Advisers LLC	11,662	$0.58M	0.2%	+59.6%	0.029%
2/11/2021	Northern Trust Corp	353,099	$17.48M	0.0%	-5.6%	0.872%
2/11/2021	Barclays PLC	12,144	$0.60M	0.0%	-75.0%	0.030%
2/11/2021	Citigroup Inc.	8,141	$0.40M	0.0%	+137.4%	0.020%
2/10/2021	Rhumbline Advisers	38,496	$1.91M	0.0%	+5.3%	0.095%
2/10/2021	Aviva PLC	32,953	$1.63M	0.0%	-44.8%	0.081%
2/10/2021	Artisan Partners Limited Partnership	1,047,416	$51.86M	0.1%	+44.3%	2.585%
2/9/2021	Wells Fargo & Company MN	26,885	$1.33M	0.0%	+63.7%	0.066%
2/9/2021	Bank of New York Mellon Corp	107,759	$5.34M	0.0%	+2.5%	0.266%
2/9/2021	ProShare Advisors LLC	13,012	$0.64M	0.0%	+28.6%	0.032%
2/8/2021	Vident Investment Advisory LLC	31,439	$1.56M	0.1%	+3.3%	0.078%
2/8/2021	Alliancebernstein L.P.	1,010,319	$50.02M	0.0%	+5.3%	2.494%
2/8/2021	New York State Common Retirement Fund	199,599	$9.88M	0.0%	+33.1%	0.493%
2/5/2021	IndexIQ Advisors LLC	8,025	$0.40M	0.0%	+11.5%	0.020%
2/5/2021	BlackRock Inc.	2,418,580	$119.74M	0.0%	+3.1%	5.970%
2/5/2021	Aperio Group LLC	5,685	$0.28M	0.0%	+8.9%	0.014%
2/5/2021	SG Americas Securities LLC	56,712	$2.81M	0.0%	-26.8%	0.140%
2/4/2021	State of Wisconsin Investment Board	48,800	$2.42M	0.0%	-13.6%	0.120%
2/2/2021	California Public Employees Retirement System	67,724	$3.35M	0.0%	-1.9%	0.167%
1/22/2021	Candriam Luxembourg S.C.A.	179,946	$8.91M	0.1%	-1.5%	0.444%
1/19/2021	DNB Asset Management AS	22,559	$1.12M	0.0%	N/A	0.056%
12/14/2020	Strs Ohio	13,800	$0.53M	0.0%	-18.8%	0.034%
12/4/2020	Sei Investments Co.	9,582	$0.37M	0.0%	+13.8%	0.024%
11/17/2020	California State Teachers Retirement System	45,657	$1.75M	0.0%	+1.1%	0.113%
11/17/2020	Jane Street Group LLC	8,864	$0.34M	0.0%	+23.9%	0.022%
11/16/2020	Squarepoint Ops LLC	15,535	$0.60M	0.0%	-4.3%	0.038%
11/13/2020	Morgan Stanley	75,392	$2.89M	0.0%	-8.0%	0.186%
11/13/2020	First Light Asset Management LLC	608,193	$23.35M	2.4%	+0.1%	1.501%
11/13/2020	ProShare Advisors LLC	10,118	$0.39M	0.0%	-2.9%	0.025%
11/13/2020	Charles Schwab Investment Management Inc.	172,240	$6.61M	0.0%	+22.3%	0.425%
11/13/2020	UBS Asset Management Americas Inc.	16,749	$0.64M	0.0%	+6.3%	0.041%
11/13/2020	Virtus ETF Advisers LLC	7,309	$0.28M	0.1%	-12.0%	0.018%
11/13/2020	Great West Life Assurance Co. Can	407,129	$3.89M	0.0%	+28,114.1%	1.005%
11/13/2020	AXA S.A.	189,197	$7.26M	0.0%	-1.0%	0.467%
11/12/2020	JPMorgan Chase & Co.	29,682	$1.20M	0.0%	-5.6%	0.073%
11/12/2020	Federated Hermes Inc.	109,152	$4.19M	0.0%	+22.9%	0.269%
11/12/2020	Sphera Funds Management LTD.	396,521	$15.22M	1.5%	+40.5%	0.979%
11/12/2020	Skandinaviska Enskilda Banken AB publ	1,000	$38K	0.0%	N/A	0.002%
11/10/2020	State Street Corp	1,049,936	$40.31M	0.0%	+9.9%	2.624%
11/9/2020	SG Americas Securities LLC	77,486	$2.98M	0.0%	+1,355.7%	0.194%
11/9/2020	The Manufacturers Life Insurance Company	17,840	$0.69M	0.0%	-1.6%	0.045%
11/9/2020	Swiss National Bank	45,100	$1.73M	0.0%	+1.6%	0.113%
11/9/2020	State Board of Administration of Florida Retirement System	8,715	$0.34M	0.0%	+7.0%	0.022%
11/6/2020	Sei Investments Co.	9,582	$0.37M	0.0%	+13.8%	0.024%
11/6/2020	BlackRock Inc.	2,345,757	$90.05M	0.0%	+1.5%	5.862%
11/6/2020	Zurcher Kantonalbank Zurich Cantonalbank	1,868	$72K	0.0%	+178.4%	0.005%
11/5/2020	New York State Common Retirement Fund	149,980	$5.76M	0.0%	+18.3%	0.375%
11/5/2020	California Public Employees Retirement System	69,024	$2.65M	0.0%	+2.8%	0.172%
11/5/2020	Alps Advisors Inc.	51,029	$1.96M	0.0%	-5.9%	0.128%
11/5/2020	Wells Fargo & Company MN	16,424	$0.63M	0.0%	-10.3%	0.041%
11/4/2020	American International Group Inc.	17,905	$0.69M	0.0%	-2.2%	0.045%
11/4/2020	Alps Advisors Inc.	51,029	$1.96M	0.0%	-5.9%	0.128%
10/30/2020	BNP Paribas Arbitrage SA	7,049	$0.27M	0.0%	+229.9%	0.018%
10/29/2020	DekaBank Deutsche Girozentrale	13,300	$0.54M	0.0%	N/A	0.033%
10/26/2020	HighMark Wealth Management LLC	2,280	$88K	0.1%	+854.0%	0.006%
10/20/2020	Nisa Investment Advisors LLC	1,150	$44K	0.0%	N/A	0.003%
10/19/2020	Candriam Luxembourg S.C.A.	182,704	$7.01M	0.1%	+10.7%	0.457%
10/19/2020	Pacer Advisors Inc.	775	$30K	0.0%	N/A	0.002%
9/15/2020	Two Sigma Advisers LP	79,300	$3.43M	0.0%	+23.1%	0.198%
9/15/2020	Schonfeld Strategic Advisors LLC	14,727	$0.64M	0.0%	-6.7%	0.037%
9/4/2020	Principal Financial Group Inc.	13,649	$0.59M	0.0%	N/A	0.034%
9/4/2020	Teachers Retirement System of The State of Kentucky	20,584	$0.89M	0.0%	-10.5%	0.051%
8/25/2020	Nuveen Asset Management LLC	151,730	$6.56M	0.0%	+40.8%	0.379%
8/20/2020	Charles Schwab Investment Management Inc.	140,881	$6.09M	0.0%	+16.6%	0.352%
8/17/2020	California State Teachers Retirement System	45,144	$1.95M	0.0%	+26.4%	0.113%
8/17/2020	Jane Street Group LLC	7,157	$0.31M	0.0%	N/A	0.018%
8/17/2020	Perceptive Advisors LLC	355,366	$15.35M	0.2%	-32.0%	0.888%
8/17/2020	Private Advisor Group LLC	3,000	$0.13M	0.0%	N/A	0.007%
8/14/2020	First Light Asset Management LLC	607,621	$26.25M	3.1%	N/A	1.518%
8/14/2020	Bank of America Corp DE	69,311	$2.99M	0.0%	+2.5%	0.173%
8/14/2020	Cormorant Asset Management LP	1,574,683	$68.03M	2.6%	-9.1%	3.935%
8/14/2020	Artal Group S.A.	300,030	$12.96M	0.4%	-25.0%	0.750%
8/14/2020	Vanguard Group Inc.	1,239,664	$53.55M	0.0%	+14.6%	3.098%
8/14/2020	Driehaus Capital Management LLC	333,860	$14.42M	0.4%	-24.9%	0.834%
8/13/2020	FMR LLC	1,310,742	$56.62M	0.0%	-5.8%	3.276%
8/13/2020	Federated Hermes Inc.	88,808	$3.84M	0.0%	N/A	0.222%
8/13/2020	Athanor Capital LP	8,460	$0.37M	0.0%	N/A	0.021%
8/12/2020	Bank of Montreal Can	2,477	$100K	0.0%	+2,215.0%	0.006%
8/12/2020	American International Group Inc.	18,311	$0.79M	0.0%	+30.8%	0.046%
8/12/2020	Goldman Sachs Group Inc.	579,878	$25.05M	0.0%	+17.2%	1.449%
8/12/2020	Barclays PLC	52,004	$2.25M	0.0%	+382.4%	0.130%
8/12/2020	Bank of New York Mellon Corp	104,603	$4.52M	0.0%	+22.4%	0.261%

Data available starting January 2016

Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment of pediatric patients with relapsed or refractory high-risk neuroblastoma. The company is also developing DANYELZA that is in Phase II clinical studies for the treatment of patients with first-line neuroblastoma, third-line neuroblastoma, and in relapsed osteosarcoma; GD2-GD3 vaccine that is in Phase II clinical trial for the treatment of Stage 4 high-risk neuroblastoma; and Omburtamab, a murine monoclonal antibody that is in clinical trials for the treatment of central nervous system/ leptomeningeal metastases from neuroblastoma, desmoplastic small round cell tumor, diffuse intrinsic pontine glioma, and other B7-H3 positive tumors. In addition, it is developing Nivatrotamab for the treatment of small cell lung cancer, as well as is in Phase I/II trial for the treatment of refractory GD2 positive adult and pediatric solid tumors; and Lu-omburtamab-DTPA that is in Phase I clinical development for the treatment of medulloblastoma and B7-H3 positive leptomeningeal metastases from solid tumors. The company has a license agreement with Memorial Sloan Kettering Cancer Center and Massachusetts Institute of Technology to develop and commercialize licensed products. Y-mAbs Therapeutics, Inc. was incorporated in 2015 and is headquartered in New York, New York.

Today's Range

Now: $26.38

$26.14

$28.45

50 Day Range

MA: $34.24

$28.34

$42.73

52 Week Range

Now: $26.38

$26.14

$55.22

Volume

615,992 shs

Average Volume

297,563 shs

Market Capitalization

$1.15 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.36

Who are the company insiders with the largest holdings of Y-mAbs Therapeutics?

Y-mAbs Therapeutics' top insider shareholders include:

Bo Kruse (CFO)
Mahiuddin Ahmed (VP)
Thomas Gad (Insider)
Pedro Claus Juan Moller-San (CEO)
Thomas Gad (Chairman)
David N Gill (Director)
James Healy (Director)
Johan Wedell-Wedellsborg (Director)
Thomas Gad (CEO)
Vignesh Rajah (CMO)

Who are the major institutional investors of Y-mAbs Therapeutics?

Y-mAbs Therapeutics' top institutional shareholders include:

Pacer Advisors Inc. — 0.00%

Which major investors are buying Y-mAbs Therapeutics stock?

Within the last quarter, YMAB stock was bought by institutional investors including:

Pacer Advisors Inc.

Within the previous year, these company insiders have bought Y-mAbs Therapeutics stock:

Bo Kruse (CFO)
Mahiuddin Ahmed (VP)
Thomas Gad (Insider)